EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease

Lukai Zheng iD, Anna Rubinski, Jannis Denecke iD, Ying Luan, Ruben Smith, Olof Strandberg, Erik Stomrud, Rik Ossenkoppele, Diana Otero Svaldi, Ixavier Alonzo Higgins, Sergey Shcherbinin, Michael J Pontecorvo und 4 weitere

Annals of Neurology · 2024-02 · 95 (2) · 274-287

DOI: 10.1002/ana.26818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 25.10.2023. Verfasst von Lukai Zheng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stroke and Dementia Research, University Hospital, LMU, Munich, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Connectome, Cognitive Dysfunction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Scholarship Council, Deutsches Zentrum für Luft- und Raumfahrt, ERA PerMed.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to test whether region‐specific factors, including spatial expression patterns of the tau‐encoding gene MAPT and regional levels of amyloid positron emission tomography (PET), enhance connectivity‐based modeling of the spatial variability in tau‐PET deposition in the Alzheimer disease (AD) spectrum.

Methods

We included 685 participants (395 amyloid‐positive participants within AD spectrum and 290 amyloid‐negative controls) with tau‐PET and amyloid‐PET from 3 studies (Alzheimer's Disease Neuroimaging Initiative, 18 F‐AV‐1451‐A05, and BioFINDER‐1). Resting‐state functional magnetic resonance imaging was obtained in healthy controls (n = 1,000) from the Human Connectome Project, and MAPT gene expression from the Allen Human Brain Atlas. Based on a brain‐parcellation atlas superimposed onto all modalities, we obtained region of interest (ROI)‐to‐ROI functional connectivity, ROI‐level PET values, and MAPT gene expression. In stepwise regression analyses, we tested connectivity, MAPT gene expression, and amyloid‐PET as predictors of group‐averaged and individual tau‐PET ROI values in amyloid‐positive participants.

Results

Connectivity alone explained 21.8 to 39.2% (range across 3 studies) of the variance in tau‐PET ROI values averaged across amyloid‐positive participants. Stepwise addition of MAPT gene expression and amyloid‐PET increased the proportion of explained variance to 30.2 to 46.0% and 45.0 to 49.9%, respectively. Similarly, for the prediction of patient‐level tau‐PET ROI values, combining all 3 predictors significantly improved the variability explained (mean adjusted R 2 range across studies = 0.118–0.148, 0.156–0.196, and 0.251–0.333 for connectivity alone, connectivity plus MAPT expression, and all 3 modalities combined, respectively).

Interpretation

Across 3 study samples, combining the functional connectome and molecular properties substantially enhanced the explanatory power compared to single modalities, providing a valuable tool to explain regional susceptibility to tau deposition in AD. ANN NEUROL 2024;95:274–287

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseConnectomeCognitive DysfunctionHumansMagnetic Resonance Imagingtau ProteinsBrainPositron-Emission TomographyAmyloidGene ExpressionAmyloid beta-Peptides

Substanzen

tau ProteinsAmyloidAmyloid beta-PeptidesMAPT protein, human

Autor:innen und Institutionen

  • Institute for Stroke and Dementia Research, University Hospital, LMU, Munich, Germany.
  • Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
  • Memory Clinic, Skåne University Hospital, Malmö, Sweden.
  • Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.
  • Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.

ORCID-Profile: Lukai Zheng, Jannis Denecke, Oskar Hansson, Nicolai Franzmeier, Michael Ewers

Förderung

  • China Scholarship Council
  • Deutsches Zentrum für Luft- und Raumfahrt
  • ERA PerMed
  • Legerlotz

Zitieren

APA

Zheng, L., Rubinski, A., Denecke, J., Luan, Y., Smith, R., Strandberg, O., Stomrud, E., Ossenkoppele, R., Svaldi, D. O., Higgins, I. A., Shcherbinin, S., Pontecorvo, M. J., Hansson, O., Franzmeier, N., Ewers, M., & Alzheimer's Disease Neuroimaging Initiative (2024). Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease. Annals of Neurology, 95(2), 274-287. https://doi.org/10.1002/ana.26818

Vancouver

Zheng L, Rubinski A, Denecke J, Luan Y, Smith R, Strandberg O, et al. Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease. Annals of Neurology. 2024;95(2):274-287. doi:10.1002/ana.26818

BibTeX
@article{Zheng2024,
  author = {Zheng, Lukai and Rubinski, Anna and Denecke, Jannis and Luan, Ying and Smith, Ruben and Strandberg, Olof and Stomrud, Erik and Ossenkoppele, Rik and Svaldi, Diana Otero and Higgins, Ixavier Alonzo and Shcherbinin, Sergey and Pontecorvo, Michael J and Hansson, Oskar and Franzmeier, Nicolai and Ewers, Michael and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease},
  journal = {Annals of Neurology},
  year = {2024},
  volume = {95},
  number = {2},
  pages = {274--287},
  doi = {10.1002/ana.26818}
}
Kostenlos starten →